Legal Opinion

Factor Bioscience Inc. v. Cellectis, Inc., Cellectis S.A. and AstraZeneca Ireland Limited

District Court, D. Delaware

Decided June 29, 2026No. 1:25-cv-01197Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FACTOR BIOSCIENCE INC., : Plaintiff, . C.A. No. 25-1197-GBW v CELLECTIS, INC., CELLECTIS S.A. and . ASTRAZENECA IRELAND LIMITED, : Defendants. MEMORANDUM ORDER Factor Bioscience Inc. (“Plaintiff’ or “Factor Bioscience” ) filed this action against Cellectis, Inc. and Cellectis S.A. (collectively, “Cellectis”) and AstraZeneca Ireland Limited (“AstraZeneca” and together with Cellectis, “Defendants”) on September 26, 2025, alleging that Defendants infringed three of its patents: U.S. Patent Nos. 10,662,410 (“the ’410 Patent”);…

2Cases cited2 opinions

  1. Falko-Gunter Falkner, Georg Holzer, and Friedrich Dorner v. Stephen C. Inglis, Michael E.G. Boursnell, and Anthony C. MinsonCourt of Appeals for the Federal Circuit · 2006
  2. Evonik Degussa GmbH v. Materia Inc.District Court, D. Delaware · 2014

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API